December 3, 2013

23andMe faces class action lawsuit in California

Genetic testing company 23andMe is facing a class action lawsuit alleging that the Silicon Valley startup misled customers about its test kit.

The test is promoted as helping predict users' disease risk based on their DNA.

The lawsuit, filed in U.S. district court in California last week, comes days after the Food and Drug Administration ordered 23andMe to halt sales of its personalized test, saying the company failed to show that the technology is supported by science.

23andMe sells its $99 test online. Customers receive a small tube in the mail, which they return to the company with a saliva sample for DNA analysis.

The lawsuit by San Diego resident Lisa Casey alleges that the test results are "meaningless."

23andMe said Tuesday that it would not comment on legal matters.

© 2013 The Associated Press. All rights reserved.

Citation: 23andMe faces class action lawsuit in California (2013, December 3) retrieved 18 April 2024 from https://medicalxpress.com/news/2013-12-23andme-class-action-lawsuit-california.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

US tells 23andMe to halt sales of genetic test
 shares

Feedback to editors
Health improvements occurred worldwide since 2010 despite COVID-19 pandemic, but progress was uneven: Study

6 hours ago
Study shows heart failure, not stroke is the most common complication of atrial fibrillation

6 hours ago
Antipsychotics for dementia linked to more harms than previously acknowledged

6 hours ago
Protecting brain cells with cannabinol: Research suggests CBN shows promise for treating neurological disorders

7 hours ago
Calorie restriction study reveals complexities in how diet impacts aging

7 hours ago
Ketamine produces wide variety of responses in the brain, researchers find

8 hours ago
Emotional radio ads may ease listeners' qualms, boosting support for organ donation

8 hours ago
To understand cognition and its dysfunction, neuroscientists must learn its rhythms

8 hours ago
New insights into the mechanisms of bacterial brain invasion during meningitis

8 hours ago
Study finds lower relapse risk in triple-negative breast cancer with high immune cell levels

8 hours ago
Load comments (0)